X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Shilpa Medicare Ltd.
BSE CODE: 530549   |   NSE CODE: SHILPAMED   |   ISIN CODE : INE790G01031   |   15-May-2026 Hrs IST
BSE NSE
Rs. 478.50
27.45 ( 6.09% )
 
Prev Close ( Rs.)
451.05
Open ( Rs.)
451.85
 
High ( Rs.)
492.00
Low ( Rs.)
450.10
 
Volume
112768
Week Avg.Volume
47965
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 478.40
27.9 ( 6.19% )
 
Prev Close ( Rs.)
450.50
Open ( Rs.)
452.30
 
High ( Rs.)
491.95
Low ( Rs.)
450.00
 
Volume
2449910
Week Avg.Volume
1055904
 
52 WK High-Low Range(Rs.)
259.5
500
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)7.14  3.10  -5.70  2.32  7.98  
   CEPS(Rs)6.07  4.41  -0.17  3.17  5.36  
   DPS(Rs)1.00  0.00  0.00  1.10  1.10  
   Book NAV/Share(Rs)276.16  246.85  243.96  237.97  200.89  
   Tax Rate(%)34.91  29.28  15.09  26.66  27.84  
Margin Ratios          
   Core EBITDA Margin(%)23.93  6.93  -22.27  3.09  11.08  
   EBIT Margin(%)23.85  17.87  -15.12  10.24  37.46  
   Pre Tax Margin(%)22.47  12.30  -23.53  7.70  35.09  
   PAT Margin (%)14.62  8.70  -19.98  5.65  25.32  
   Cash Profit Margin (%)24.86  24.71  -1.19  15.40  33.99  
Performance Ratios          
   ROA(%)2.57  1.09  -1.83  0.74  2.87  
   ROE(%)2.88  1.26  -2.37  1.09  4.21  
   ROCE(%)4.47  2.36  -1.61  1.61  4.67  
   Asset Turnover(x)0.18  0.13  0.09  0.13  0.11  
   Sales/Fixed Asset(x)0.57  0.38  0.32  0.43  0.31  
   Working Capital/Sales(x)1.91  1.89  0.63  2.42  0.84  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.76  2.65  3.10  2.30  3.26  
   Receivable days127.83  150.65  158.13  164.12  315.80  
   Inventory Days99.59  121.60  144.60  204.94  358.76  
   Payable days123.03  194.46  139.04  218.12  479.17  
Valuation Parameters          
   PER(x)92.88  148.66  0.00  171.02  41.81  
   PCE(x)54.64  52.31  -678.18  62.71  31.15  
   Price/Book(x)2.40  1.87  0.94  1.67  1.66  
   Yield(%)0.15  0.00  0.00  0.28  0.33  
   EV/Net Sales(x)13.80  13.37  9.18  10.16  12.68  
   EV/Core EBITDA(x)31.60  35.90  92.25  57.96  49.68  
   EV/EBIT(x)57.85  74.85  -60.70  99.22  33.85  
   EV/CE(x)2.35  1.81  0.95  1.60  1.42  
   M Cap / Sales13.58  12.93  8.04  9.66  10.59  
Growth Ratio          
   Net Sales Growth(%)54.09  25.06  -30.61  38.86  -68.11  
   Core EBITDA Growth(%)80.61  368.32  -60.60  -4.68  -74.39  
   EBIT Growth(%)105.69  247.78  -202.49  -62.05  -55.56  
   PAT Growth(%)159.13  154.44  -345.47  -69.03  -61.30  
   EPS Growth(%)130.01  154.44  -345.48  -70.91  -61.30  
Financial Stability Ratios          
   Total Debt/Equity(x)0.04  0.07  0.14  0.09  0.40  
   Current Ratio(x)2.10  1.77  2.62  1.91  1.65  
   Quick Ratio(x)1.45  1.25  2.26  1.36  1.01  
   Interest Cover(x)17.24  3.21  -1.80  4.04  15.85  
   Total Debt/Mcap(x)0.02  0.04  0.14  0.06  0.24